Geneos Wealth Management’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.05K Sell
705
-334
-32% -$3.48K ﹤0.01% 2077
2025
Q4
$10.5K Hold
1,039
﹤0.01% 1948
2025
Q3
$9.32K Sell
1,039
-3,602
-78% -$34.7K ﹤0.01% 1981
2025
Q2
$48.1K Sell
4,641
-8,934
-66% -$94.2K ﹤0.01% 1593
2025
Q1
$140K Buy
13,575
+9,932
+273% +$97.8K ﹤0.01% 1390
2024
Q4
$34.8K Buy
+3,643
New +$35.6K ﹤0.01% 1467

Other funds holding HLN

Geneos Wealth Management's HLN Position: Q1 2026 in Review

Geneos Wealth Management reduced its Haleon (HLN) stake by 32% in Q1 2026, selling an estimated $3.48K and leaving 705 shares worth $7.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Geneos Wealth Management first reported a position in HLN in Q4 2024 and has held it in 6 quarters since. The position peaked at $140K in Q1 2025. 620 funds tracked by Wall St. Rank hold HLN as of Q1 2026.

  • Geneos Wealth Management held 705 shares of Haleon worth $7.05K as of Q1 2026.
  • Geneos Wealth Management sold 334 Haleon shares in Q1 2026, an estimated $3.48K.
  • Haleon made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2077 holding.
  • Geneos Wealth Management first reported a position in Haleon in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's Haleon position peaked at $140K in Q1 2025.
  • 620 funds tracked by Wall St. Rank held Haleon as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.